Premature Ovarian Insufficiency and Long-Term Health Consequences.
Tsiligiannis S, Panay N, Stevenson JC.
Curr Vasc Pharmacol. 2019;17(6):604-609. doi: 10.2174/1570161117666190122101611.
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E, Paschou SA, Goulis DG, Lambrinoudaki I.
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101561. doi: 10.1016/j.beem.2021.101561. Epub 2021 Jun 30.
PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Chen S, Chen J, Du W, Mickelsen DM, Shi H, Yu H, Kumar S, Yan C.
Circ Res. 2023 Jul 7;133(2):138-157. doi: 10.1161/CIRCRESAHA.122.322264. Epub 2023 May 26.
Flometoquin (Pesticides).
Food Safety Commission of Japan.
Food Saf (Tokyo). 2017 Sep 29;5(3):114-117. doi: 10.14252/foodsafetyfscj.2017008s. eCollection 2017 Sep.
Mechanisms of Ovarian Cancer-Associated Cachexia.
Callaway CS, Mouchantat LM, Bitler BG, Bonetto A.
Endocrinology. 2023 Nov 20;165(1):bqad176. doi: 10.1210/endocr/bqad176.
Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer.
Delfinis LJ, Khajehzadehshoushtar S, Flewwelling LD, Andrews NJ, Garibotti MC, Gandhi S, Brahmbhatt AN, Morris BA, Garlisi B, Lauks S, Aitken C, Ogilvie L, Tsitkanou S, Simpson JA, Greene NP, Cheng AJ, Petrik J, Perry CGR.
Mol Metab. 2025 Sep;99:102211. doi: 10.1016/j.molmet.2025.102211. Epub 2025 Jul 16.
Sexuality in premature ovarian insufficiency.
Nappi RE, Cucinella L, Martini E, Rossi M, Tiranini L, Martella S, Bosoni D, Cassani C.
Climacteric. 2019 Jun;22(3):289-295. doi: 10.1080/13697137.2019.1575356. Epub 2019 Mar 22.
Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies.
Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X.
Cancer Med. 2020 Nov;9(21):7964-7978. doi: 10.1002/cam4.3428. Epub 2020 Sep 13.
ATAXIA-TELANGIECTASIA.
DUNN HG, MEUWISSEN H, LIVINGSTONE CS, PUMP KK.
Can Med Assoc J. 1964 Nov 21;91(21):1106-18.
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy.
Costa APF, Sarmento ACA, Vieira-Baptista P, Eleutério J Jr, Cobucci RN, Gonçalves AK.
Front Reprod Health. 2021 Nov 29;3:783247. doi: 10.3389/frph.2021.783247. eCollection 2021.
